ETF Holdings Breakdown of NUVL

Stock NameNuvalent Inc
TickerNUVL(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS6707031075

News associated with NUVL

First Trust Advisors LP Raises Stake in Nuvalent, Inc. (NASDAQ:NUVL)
First Trust Advisors LP lifted its position in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 3.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 44,542 shares of the company’s stock after purchasing an additional 1,685 shares during the period. […] - 2025-05-04 08:30:55
Nuvalent, Inc. (NASDAQ:NUVL) Shares Bought by Commonwealth Equity Services LLC
Commonwealth Equity Services LLC increased its holdings in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 13.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,618 shares of the company’s stock after purchasing an additional 309 shares during the period. […] - 2025-04-11 07:28:50
Sei Investments Co. Has $549,000 Stock Holdings in Nuvalent, Inc. (NASDAQ:NUVL)
Sei Investments Co. trimmed its position in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 44.6% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 7,016 shares of the company’s stock after selling 5,659 shares during the period. Sei Investments Co.’s holdings in Nuvalent were worth $549,000 as of its most recent filing with […] - 2025-04-10 07:18:52
Corebridge Financial Inc. Decreases Stake in Nuvalent, Inc. (NASDAQ:NUVL)
Corebridge Financial Inc. lessened its position in shares of Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 5.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,472 shares of the company’s stock after selling 1,051 shares during the quarter. Corebridge Financial Inc.’s […] - 2025-04-04 08:41:03
US Bancorp DE Makes New $90,000 Investment in Nuvalent, Inc. (NASDAQ:NUVL)
US Bancorp DE acquired a new stake in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 1,156 shares of the company’s stock, valued at approximately $90,000. A number of other hedge funds have also modified […] - 2025-03-18 07:12:56
Nuvalent, Inc. (NASDAQ:NUVL) Holdings Lifted by abrdn plc
abrdn plc raised its position in Nuvalent, Inc. (NASDAQ:NUVL – Free Report) by 19.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 56,701 shares of the company’s stock after purchasing an additional 9,241 shares during the quarter. abrdn plc owned about 0.08% of Nuvalent […] - 2025-02-10 18:42:58

NUVL institutional holdings

The following institutional investment holdings of NUVL have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-08 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 24,523USD 1,755,847
2025-05-08 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 4,115USD 294,634 6.8%
2025-05-08 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 31,504USD 2,255,686
2025-05-08 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 31,504USD 2,255,686 6.8%
2025-05-08 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 111USD 7,948
Total =91,757 USD 6,569,801
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.